Managing hepatocellular carcinoma across the stages: efficacy and outcomes of stereotactic body radiotherapy : A retrospective study.

Ahmed Allam MohamedMarie-Luise BerresPhilipp BrunersSven Arke LangChristian TrautweinGeorg WiltbergerAlexandra BarabaschMichael Eble

Published in: Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] (2024)

SBRT offers a compelling option for achieving high local control and promising survival outcomes in HCC. The study supports a radiation dose range of 61-73.1 Gy, coupled with a mean liver dose under 12.6-12.8 Gy as EQD2, to achieve favorable FFLP rates, with acceptable toxicity rates.

Keyphrases

radiation therapy
early stage
oxidative stress
locally advanced
squamous cell carcinoma
metabolic syndrome
skeletal muscle
rectal cancer